Mission Summit

Mission Summit is a foundation which has its origin in 2011 when 9 friends climbed Kilimanjaro. Shortly before the ascent would take place, one of the participants (Niels van Buren) was diagnosed with MS. This has motivated him and his friends to raise money for research into MS. Now the team goes a step further with the ascent of other mountains with the ultimate aim of reaching the summit of Mount Everest!

Mountaineer Niels van Buren climbs Mount Everest and other mountains to raise money for research into MS (Project Y) and to ask attention for MS and MS patients. What makes Mission Summit unique? Niels van Buren has become the first man with MS to summit Mount Everest! This way we hope to inspire others to also get into action.

Niels van Buren is the man of the action. Shortly after he was diagnosed with MS, he ran with the VU university building course and raised more money than the main sponsor. In 2011 he climbed Mount Kilimanjaro along with 8 friends and raised € 35,000 -. With the Round Table, of which Niels is a member, he organizes an annual wine event for the benefit of MS research and in May 2013 and 2014 he cycled with friends and family the Mont Ventoux 3 times during the event Climbing Against MS. The new goal: climbing Mount Everest!

"This huge challenge requires intense physical and technical climbing training, plus a good (financial) planning," Niels van Buren explains. "The actions are certainly a way for me to deal with MS. It gives me a lot of energy and satisfaction. The financial goal, making plans with others and the kick if it works: that’s really fantastic. I also hope to inspire others to move. And I’m fortunate I can do this, because there is still little physical deterioration because of my MS. "

"I realized that with the foundation of Mission Summit (climb of Kilimanjaro) everyone would come to know that I have MS: at work, in sports ... I could not oversee the consequences at the time. The deciding factor was that people who knew about my MS, responded very positively and because I foresaw that we would raise a serious amount of money with the initiative. It turned out to be a nice way to bring out the bad news. Everyone liked the initiative a lot. When I explained why the goal was MS research, the conversation could turn back to the initiative instead of my situation. This way there were less awkward silences. Now the idea is more or less ‘ingrained’ and I can be just Niels once again."